This page shows the latest Janssen news and features for those working in and with pharma, biotech and healthcare.
Janssen – a pharmaceutical arm of Johnson &Johnson – has announced that Stelara (ustekinumab) has been approved by the US Food and Drug Administration (FDA) for the treatment of paediatric patients aged six ... Commenting on the approval, Jennifer
The Janssen Pharmaceutical Companies of Johnson &Johnson has announced new data from a phase 1b/2 study, supporting the safety and efficacy of the combination treatment of Rybrevant (amivantamab-vmjw) and
Authorisation of Janssen COVID-19 vaccine restricted among certain people following analysis and evaluation. ... The Janssen COVID-19 vaccine was authorised for emergency use in February 2021.
Amgen has announced preliminary results from a phase 3 study evaluating the efficacy and safety of its drug candidate ABP 654 compared to Janssen’s Stelara in adult patients with moderate
The Janssen Pharmaceutical Companies of Johnson &Johnson has announced Tremfya (guselkumab) demonstrated consistent and durable skin clearance. ... Despite effective medical treatments for the disease, people living with psoriasis can experience
while working with Janssen to understand the impact COVID-19 can have on a patient’s immune system immediately after receiving a positive test result.
More from news
Approximately 153 fully matching, plus 419 partially matching documents found.
It’s exactly how we are at Janssen now, and I am thankful to have a team dedicated to driving the science forwards. ... Neil Davie is Head of Late Development, Cardiovascular, Metabolism &Pulmonary Hypertension at the Janssen Pharmaceutical Companies
Lee-Ann Farrell comments: “I’m committed to championing all DE&I efforts throughout Janssen. ... References are available on request. This article has been commissioned by, and developed by, Janssen-Cilag Ltd.
And the list goes on. So it seems, encouragingly, that health and pharma brands – from Pfizer to Teva and Roche Genentech to Janssen – seem to finally be recognising the power of
For the past 20 years, true understanding of the patient experience has been the turnkey for R&D for therapies in pulmonary arterial hypertension (PAH) at Janssen Pulmonary Hypertension (following the ... PAH treatment strategies or interventions, an
Joaquín Casariego García-Lubén talks to PME about how Janssen is driven by the premise of providing personalised treatment solutions in cancer care. ... Joaquín Casariego García-Lubén is EMEA Therapeutic Area Lead Oncology, The Janssen
More from intelligence
Approximately 5 fully matching, plus 56 partially matching documents found.
Prior to Genmab, Ahmadi worked as head of experimental medicine and early development oncology at Janssen.
During her time at J&J, Torres held several executive leadership roles including president of McNeil Consumer Healthcare and president of Janssen Pharmaceuticals, CNS.
He has also served in various executive leadership roles at Novartis Pharma and Novartis Oncology, and he began his career at Johnson &Johnson and Janssen.
He has previously held roles for ProQR Therapeutics, Janssen BioTherapeutics, and MorphoSys.
Prior to his time at Mundipharma, he served Napp Pharmaceuticals and Janssen in various capacities.
More from appointments
Approximately 3 fully matching, plus 27 partially matching documents found.
Copywriting. AKLRD | A Life in a Day | Allergan | Amgen | Arquer Diagnostics | Bleepa | Boehringer Ingelheim | Galapagos | Inivata | Janssen | Kantar | Maxwellia | Macmillan | Mundipharma | Norgine | Novo Nordisk | Pfizer | Roche | Sanofi | Santen |
Working with global pharma clients such as Takeda, GSK, Janssen and Abbvie, the consultancy is on a trajectory for growth and has doubled in size due to its commitment to technology,
Recently, Darzalex (daratumumab), a monoclonal antibody developed by Genmab and Janssen, that has been available for the management of patients with multiple myeloma across Europe for 5 years, was granted accelerated
READ MORE ABOUT OUR WINNING PROJECT WITH WITH JANSSEN BELOW:. The Immunology Training Summit (ITS) 2020 with the Janssen EMEA Immunology team took a week-long face-to-face meeting for ... Strikingly this format is now considered best practice in
Clinigen. Crohns and Colitis Department for International Development. Eisai. Gilead. Janssen.
More from PMHub
Approximately 5 fully matching, plus 31 partially matching documents found.
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...